Cholecystokinin-From local gut hormone to ubiquitous messenger

Frontiers in Endocrinology

Volumn 8, Issue APR, 2017, Pages

  Rehfeld, Jens F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cholecystokinin; Gastrointestinal hormones; Neuroendocrine tumors; Neuropeptides; Tumor markers

Indexed keywords

CCK 5 PROTEIN; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; TETRAGASTRIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; BIOGENESIS; CARDIAC MUSCLE CELL; ENTEROENDOCRINE CELL; ENZYME RELEASE; GASTROINTESTINAL MOTILITY; GENE EXPRESSION; GERM CELL; HORMONE RELEASE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; KIDNEY CELL; PROTEIN EXPRESSION; SATIETY RESPONSE; SHORT SURVEY; STOMACH ACID SECRETION;

EID: 85018261657     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2017.00047     Document Type: Short Survey

References (122)

1. Larsson LI, Rehfeld JF. Evidence for a common evolutionary origin of gastrin and cholecystokinin. Nature (1977) 269:335-8. doi: 10.1038/269335a0
2. Johnsen AH. Phylogeny of the cholecystokinin/gastrin family. Front Neuroendocrinol (1998) 19:73-99. doi:10.1006/frne.1997.0163
3. Johnsen AH, Rehfeld JF. Cionin: a disulfotyrosyl hybrid of cholecystokinin and gastrin from the neural ganglion of the protochordate ciona intestinalis. J Biol Chem (1990) 265:3054-8.
4. Nachman RJ, Holman GM, Haddon WF, Ling N. Leucosulfakinin, a sulfated insect neuropeptide with homology to gastrin and cholecystokinin. Science (1986) 234:71-3. doi:10.1126/science.3749893
5. Nichols R, Schneuwly SA, Dixon JE. Identification and characterization of a Drosophila homologue to the vertebrate neuropeptide cholecystokinin. J Biol Chem (1988) 263:12167-70.
6. Ivy AC, Oldberg E. A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol (1928) 86:559-613.
7. Jorpes JE, Mutt V. Secretin, cholecystokinin and pancreozymin. In: Jorpes JE, Mutt V, editors. Handbook of Experimental Pharmacology. (Vol. 34), New York: Springer Verlag (1973). p. 1-179.
8. Rehfeld JF. Cholecystokinin. Best Pract Res Clin Endocrinol Metab (2004) 18:569-86. doi:10.1016/j.beem.2004.07.002
9. Rehfeld JF, Friis-Hansen L, Goetze JP, Hansen TV. The biology of cholecystokinin and gastrin peptides. Curr Top Med Chem (2007) 7:1154-65. doi:10.2174/156802607780960483
10. Rehfeld JF. How to measure cholecystokinin in plasma? Gastroenterology (1984) 87:434-8.
11. Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin Chem (1998) 44:991-1001.
12. Rehfeld JF. How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid. Regul Pept (1998) 78:31-9. doi:10.1016/S0167-0115(98)00133-5
13. Mutt V, Jorpes JE. Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem (1968) 6:156-62. doi:10.1111/j.1432-1033.1968.tb00433.x
14. Mutt V, Jorpes JE. Hormonal polypeptides of the upper intestine. Biochem J (1971) 125:57-8. doi:10.1042/bj1250057P
15. Morley JS, Tracy HJ, Gregory RA. Structure-function relationships in the active C-terminal tetrapeptide sequence of gastrin. Nature (1965) 207:1356-9. doi:10.1038/2071356a0
16. Rehfeld JF, Hansen HF. Characterization of preprocholecystokinin products in the porcine cerebral cortex. Evidence of different processing pathways. J Biol Chem (1986) 261:5832-40.
17. Rehfeld JF, Johnsen AH, Ødum L, Bardram L, Schifter S, Scopsi L. Non-sulphated cholecystokinin in human medullary thyroid carcinomas. J Endocrinol (1990) 124:501-6. doi:10.1677/joe.0.1240501
18. Bonetto V, Jörnvall H, Andersson M, Renlund S, Mutt V, Sillard R. Isolation and characterization of sulfated and nonsulfated forms of cholecystokinin-58 and their action on gallbladder contraction. Eur J Biochem (1999) 264:336-40. doi:10.1046/j.1432-1327.1999.00599.x
19. Reeve JR Jr, Liddle RA, McVey DC, Vigna SR, Solomon TE, Keire DA. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties. Am J Physiol Gastrointest Liver Physiol (2004) 287:G326-33. doi:10.1152/ajpgi.00520.2003
20. Agersnap M, Rehfeld JF. Nonsulfated cholecystokinins in the small intestine of pigs and rats. Peptides (2015) 71:121-7. doi:10.1016/j.peptides.2015.07.010
21. Bardram L, Rehfeld JF. Processing-independent radioimmunoanalysis: a general analytical principle applied to progastrin and its products. Anal Biochem (1988) 175:537-43. doi:10.1016/0003-2697(88)90580-5
22. Paloheimo LI, Rehfeld JF. A processing-independent assay for human procholecystokinin and its products. Clin Chim Acta (1994) 229:49-65. doi:10.1016/0009-8981(94)90228-3
23. Deschenes RJ, Haun RS, Funckes CL, Dixon JE. A gene encoding rat cholecystokinin. Isolation, nucleotide sequence, and promoter activity. J Biol Chem (1985) 260:1280-6.
24. Nielsen FC, Pedersen K, Hansen TV, Rourke IJ, Rehfeld JF. Transcriptional regulation of the human cholecystokinin gene: composite action of upstream stimulatory factor, Sp1, and members of the CREB/ATF-AP-1 family of transcription factors. DNA Cell Biol (1996) 15:53-63. doi:10.1089/dna.1996.15.53
25. Hansen TV. Cholecystokinin gene transcription: promoter elements, transcription factors and signaling pathways. Peptides (2001) 22:1201-11. doi:10.1016/S0196-9781(01)00443-0
26. Rourke IJ, Hansen TV, Nerlov C, Rehfeld JF, Nielsen FC. Negative cooperativity between juxtaposed E-box and cAMP/TPA responsive elements in the cholecystokinin gene promoter. FEBS Lett (1999) 448:15-8. doi:10.1016/S0014-5793(99)00320-8
27. Hansen TV, Rehfeld JF, Nielsen FC. Function of the C-36 to T polymorphism in the human cholecystokinin gene promoter. Mol Psychiatry (2000) 5:443-7. doi:10.1038/sj.mp.4000705
28. Hansen TV, Rehfeld JF, Nielsen FC. Mitogen-activated protein kinase and protein kinase A signaling pathways stimulate cholecystokinin transcription via activation of cyclic adenosine 3', 5'-monophosphate response element-binding protein. Mol Endocrinol (1999) 13:466-75. doi:10.1210/mend.13.3.0257
29. Deavall DG, Raychowdhury R, Dockray GJ, Dimaline R. Control of CCK gene transcription by PACAP in STC-1 cells. Am J Physiol Gastrointest Liver Physiol (2000) 279:G605-12.
30. Bernard C, Sutter A, Vinson C, Ratineau C, Chayvialle J, Cordier-Bussat M. Peptones stimulate intestinal cholecystokinin gene transcription via cyclic adenosine monophosphate response element-binding factors. Endocrinology (2001) 142:721-9. doi:10.1210/endo.142.2.7924
31. Gevrey JC, Cordier-Bussat M, Nemoz-Gaillard E, Chayvialle JA, Abello J. Co-requirement of cyclic AMP-and calcium-dependent protein kinases for transcriptional activation of cholecystokinin gene by protein hydrolysates. J Biol Chem (2002) 277:22407-13. doi:10.1074/jbc.M201624200
32. Hansen TV, Rehfeld JF, Nielsen FC. KCl and forskolin synergistically up-regulate cholecystokinin gene expression via coordinate activation of CREB and the co-activator CBP. J Neurochem (2004) 89:15-23. doi:10.1046/j.1471-4159.2003.02252.x
33. Deschenes RJ, Lorenz L, Haun RS, Roos BR, Collier KJ, Dixon JE. Cloning and sequence analysis of cDNA encoding rat preprocholecystokinin. Proc Natl Acad Sci U S A (1984) 81:726-30. doi:10.1073/pnas.81.3.726
34. Gubler U, Chua AO, Hoffman BJ, Collier KJ, Eng J. Cloned cDNA to cholecystokinin mRNA predicts an identical preprocholecystokinin in pig brain and gut. Proc Natl Acad Sci U S A (1984) 81:4307-10. doi:10.1073/pnas.81.14.4307
35. Goltermann N, Rehfeld JF, Roigaard-Petersen H. In vivo biosynthesis of cholecystokinin in rat cerebral cortex. J Biol Chem (1980) 255:6181-5.
36. Jorpes JE, Mutt V. Cholecystokinin and pancreozymin, one single hormone? Acta Physiol Scand (1966) 66:196-202. doi:10.1111/j.1748-1716.1966.tb03185.x
37. Dockray GJ, Gregory RA, Huchinson JB, Harris JI, Runswick MJ. Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain. Nature (1978) 274:711-3. doi:10.1038/274711a0
38. Reeve JR Jr, Eysselein V, Walsh JH, Ben-Avram CM, Shively JE. New molecular forms of cholecystokinin. Microsequence analysis of forms previously characterized by chromatographic methods. J Biol Chem (1986) 261:16392-7.
39. Rehfeld JF. Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem (1978) 253:4022-30.
40. Agersnap M, Zhang MD, Harkany T, Hökfelt T, Rehfeld JF. Nonsulfated cholecystokinins in cerebral neurons. Neuropeptides (2016) 60:37-44. doi:10.1016/j.npep.2016.08.003
41. Buffa R, Solcia E, Go VL. Immunohistochemical identification of the cholecystokinin cell in the intestinal mucosa. Gastroenterology (1976) 70:528-30.
42. Larsson LI, Rehfeld JF. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res (1979) 165:201-18. doi:10.1016/0006-8993(79)90554-7
43. Rehfeld JF. Procholecystokinin processing in the normal human anterior pituitary. Proc Natl Acad Sci U S A (1987) 84:3019-23. doi:10.1073/pnas.84.9.3019
44. Rehfeld JF, Lindholm J, Andersen BN, Bardram L, Cantor P, Fenger M, et al. Pituitary tumors containing cholecystokinin. N Engl J Med (1987) 316:1244-7. doi:10.1056/NEJM198705143162004
45. Hökfelt T, Rehfeld JF, Skirboll L, Ivemark B, Goldstein M, Markey K. Evidence for co-existence of dopamine and CCK in meso-limbic neurons. Nature (1980) 285:476-8. doi:10.1038/285476a0
46. Crawley JN. Comparative distribution of cholecystokinin and other neuropeptides. Why is this peptide different from all other peptides? Ann N Y Acad Sci (1985) 448:1-8. doi:10.1111/j.1749-6632.1985.tb29900.x
47. Fallon JH, Seroogy KB. The distribution and some connections of cholecystokinin neurons in the rat brain. Ann N Y Acad Sci (1985) 448:121-32. doi:10.1111/j.1749-6632.1985.tb29912.x
48. Hendry SH, Jones EG, Beinfeld MC. Cholecystokinin-immunoreactive neurons in rat and monkey cerebral cortex make symmetric synapses and have intimate associations with blood vessels. Proc Natl Acad Sci U S A (1983) 80:2400-4. doi:10.1073/pnas.80.8.2400
49. Vizi SE, Bertaccini G, Impiciattore M, Knoll J. Evidence that acetylcholine released by gastrin and related peptides contributes to their effect on gastrointestinal motility. Gastroenterology (1973) 64:268-77.
50. Larsson LI, Rehfeld JF. Peptidergic and adrenergic innervation of pancreatic ganglia. Scand J Gastroenterol (1979) 14:433-7.
51. Rehfeld JF, Larsson LI, Goltermann N, Schwartz TW, Holst JJ, Jensen SL, et al. Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature (1980) 284:33-8. doi:10.1038/284033a0
52. Dockray GJ, Gregory RA, Tracy HJ, Zhou WY. Transport of cholecystokinin-octapeptide-like immunoreactivity towards the gut in afferent vagal fibres in cat and dog. J Physiol (1981) 314:501-11. doi:10.1113/jphysiol.1981.sp013721
53. Rehfeld JF, Lundberg J. Cholecystokinin in feline vagal and sciatic nerves: concentration, molecular forms and transport velocity. Brain Res (1983) 275:341-7. doi:10.1016/0006-8993(83)90995-2
54. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest (1985) 75:1144-52. doi:10.1172/JCI111809
55. Himeno S, Tarui S, Kanayama S, Kuroshima T, Shinomura Y, Hayashi C, et al. Plasma cholecystokinin responses after ingestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: analysis with region specific radioimmunoassays. Am J Gastroenterol (1983) 78:703-7.
56. Dodd PR, Edwardson JA, Dockray GJ. The depolarisation-induced release of cholecystokinin octapeptide from rat synaptosomes and brain slices. Regul Pept (1980) 1:17-29. doi:10.1016/0167-0115(80)90003-8
57. Emson PC, Lee CM, Rehfeld JF. Cholecystokinin octapeptide: vesicular localization and calcium dependent release from rat brain in vitro. Life Sci (1980) 26:2157-63. doi:10.1016/0024-3205(80)90603-7
58. Rehfeld JF, Hansen HF, Larsson LI, Stengaard-Pedersen K, Thorn NA. Gastrin and cholecystokinin in pituitary neurons. Proc Natl Acad Sci U S A (1984) 81:1902-5. doi:10.1073/pnas.81.6.1902
59. Maton PN, Selden AC, Chadwick VS. Differential distribution of molecular forms of cholecystokinin in human and porcine small intestinal mucosa. Regul Pept (1984) 8:9-19. doi:10.1016/0167-0115(84)90024-7
60. Rehfeld JF, Holst JJ, Jensen SL. The molecular nature of vascularly released cholecystokinin from the isolated perfused porcine duodenum. Regul Pept (1982) 3:15-28. doi:10.1016/0167-0115(82)90003-9
61. Rehfeld JF, Sun G, Christensen T, Hillingsø JG. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab (2001) 86:251-8. doi:10.1210/jcem.86.1.7148
62. Hornnes PJ, Kühl C, Holst JJ, Lauritzen KB, Rehfeld JF, Schwartz TW. Simultaneous recording of the gastro-entero-pancreatic hormonal peptide response to food in man. Metabolism (1980) 29:777-9. doi:10.1016/0026-0495(80)90203-6
63. Anagnostides AA, Chadwick VS, Selden AC, Barr J, Maton PN. Human pancreatic and biliary responses to physiological concentrations of cholecystokinin octapeptide. Clin Sci (Lond) (1985) 69:259-63. doi:10.1042/cs0690259
64. Kerstens PJ, Lamers CB, Jansen JB, de Jong AJ, Hessels M, Hafkenscheid JC. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. Life Sci (1985) 36:565-9. doi:10.1016/0024-3205(85)90638-1
65. Solomon TE, Yamada T, Elashoff J, Wood J, Beglinger C. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33. Am J Physiol (1984) 247:G105-11.
66. Wank SA, Harkins R, Jensen RT, Shapira H, de Weerth A, Slattery T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci U S A (1992) 89:3125-9. doi:10.1073/pnas.89.7.3125
67. Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci U S A (1992) 89:3605-9. doi:10.1073/pnas.89.8.3605
68. Chen D, Zhao CM, Håkanson R, Samuelson LC, Rehfeld JF, Friis-Hansen L. Altered control of gastric acid secretion in gastrin-cholecystokinin double mutant mice. Gastroenterology (2004) 126:476-87. doi:10.1053/j.gastro.2003.11.012
69. You ZB, Herrera-Marschitz M, Pettersson E, Nylander I, Goiny M, Shou HZ, et al. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity. Neuroscience (1996) 74:793-804. doi:10.1016/0306-4522(96)00149-2
70. Honda T, Wada E, Battey JF, Wank SA. Differential gene expression of CCK(A) and CCK(B) receptors in the rat brain. Mol Cell Neurosci (1993) 4:143-54. doi:10.1006/mcne.1993.1018
71. Pisegna JR, de Weerth A, Huppi K, Wank SA. Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem Biophys Res Commun (1992) 189:296-303. doi:10.1016/0006-291X(92)91557-7
72. Lee YM, Beinborn M, McBride EW, Lu M, Kolakowski LF Jr, Kopin AS. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem (1993) 268:8164-9.
73. Saillan-Barreau C, Dufresne M, Clerc P, Sanchez D, Corominola H, Moriscot C, et al. Evidence for a functional role of the cholecystokinin-B/gastrin receptor in human fetal and adult pancreas. Diabetes (1999) 48:2015-21. doi:10.2337/diabetes.48.10.2015
74. Shaw RA, Jones RS. The choleretic action of cholecystokinin and cholecystokinin octapeptide in dogs. Surgery (1978) 84:622-5.
75. Dyck WP, Martin GA, Ratliff CR. Influence of secretin and cholecystokinin on intestinal alkaline phosphatase secretion. Gastroenterology (1973) 64:599-602.
76. Dyck WP, Bonnet D, Lasater J, Stinson C, Hall FF. Hormonal stimulation of intestinal disaccharidase release in the dog. Gastroenterology (1974) 66:533-8.
77. Götze H, Götze J, Adelson JW. Studies on intestinal enzyme secretion; the action of cholecystokinin-pancreozymin, pentagastrin and bile. Res Exp Med (Berl) (1978) 173:17-25. doi:10.1007/BF01851370
78. Bragado MJ, Tashiro M, Williams JA. Regulation of the initiation of pancreatic digestive enzyme protein synthesis by cholecystokinin in rat pancreas in vivo. Gastroenterology (2000) 119:1731-9. doi:10.1053/gast.2000.20242
79. Williams JA. Intracellular signaling mechanisms activated by cholecystokinin-regulating synthesis and secretion of digestive enzymes in pancreatic acinar cells. Annu Rev Physiol (2001) 63:77-97. doi:10.1146/annurev.physiol.63.1.77
80. Rothman SS, Wells H. Enhancement of pancreatic enzyme synthesis by pancreozymin. Am J Physiol (1967) 213:215-8.
81. Debas HT, Grossman MI. Pure cholecystokinin: pancreatic protein and bicarbonate response. Digestion (1973) 9:469-81. doi:10.1159/000197476
82. Soudah HC, Lu Y, Hasler WL, Owyang C. Cholecystokinin at physiological levels evokes pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol (1992) 263:G102-7.
83. Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology (2001) 121:1380-90. doi:10.1053/gast.2001.29557
84. Owyang C, Logsdon CD. New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology (2004) 127:957-69. doi:10.1053/j.gastro.2004.05.002
85. Jensen SL, Rehfeld JF, Holst JJ, Nielsen OV, Fahrenkrug J, Schaffalitzky de Muckadell OB. Secretory effects of cholecystokinins on the isolated perfused porcine pancreas. Acta Physiol Scand (1981) 111:225-31. doi:10.1111/j.1748-1716.1981.tb06730.x
86. Hermansen K. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8 and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagons secretion in the dog: studies in vitro. Endocrinology (1984) 114:1770-5. doi:10.1210/endo-114-5-1770
87. Otsuki M, Sakamoto C, Yuu H, Maeda M, Morita S, Ohki A, et al. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas. J Clin Invest (1979) 63:478-84. doi:10.1172/JCI109325
88. Monstein HJ, Nylander AG, Salehi A, Chen D, Lundquist I, Håkanson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scand J Gastroenterol (1996) 31:383-90. doi:10.3109/00365529609006415
89. Petersen H, Solomon T, Grossman MI. Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats. Am J Physiol (1978) 234:E286-93.
90. Schultzberg M, Hökfelt T, Nilsson G, Terenius L, Rehfeld JF, Brown M, et al. Distribution of peptide-and catecholamine-containing neurons in the gastro-intestinal tract of rat and guinea-pig: immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine beta-hydroxylase. Neuroscience (1980) 5:689-744.
91. Gutiérrez JG, Chey WY, Dinoso VP. Actions of cholecystokinin and secretin on the motor activity of the small intestine in man. Gastroenterology (1974) 67:35-41.
92. Gibbs J, Young RC, Smith GP. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature (1973) 245:323-5. doi:10.1038/245323a0
93. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science (1981) 213:1036-7. doi:10.1126/science.7268408
94. Reubi JC, Waser B, Gugger M, Friess H, Kleeff J, Kayed H, et al. Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue. Gastroenterology (2003) 125:98-106. doi:10.1016/S0016-5085(03)00697-8
95. Dufresne M, Seva C, Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev (2006) 86:805-47. doi:10.1152/physrev.00014.2005
96. Rehfeld JF. Accumulation of nonamidated preprogastrin and preprocholecystokinin products in porcine pituitary corticotrophs. Evidence of post-translational control of cell differentiation. J Biol Chem (1986) 261:5841-7.
97. Reubi JC, Waser B. Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas. Int J Cancer (1996) 67:644-7. doi:10.1002/(SICI)1097-0215(19960904)67:5<644::AID-IJC9>3.0.CO;2-U
98. Bardram L, Hilsted L, Rehfeld JF. Cholecystokinin, gastrin and their precursors in pheochromocytomas. Acta Endocrinol (1989) 120:479-84.
99. Persson H, Ericsson A, Schalling M, Rehfeld JF, Hökfelt T. Detection of cholecystokinin in spermatogenic cells. Acta Physiol Scand (1988) 134:565-6. doi:10.1111/j.1748-1716.1998.tb08534.x
100. Persson H, Rehfeld JF, Ericsson A, Schalling M, Pelto-Huikko M, Hökfelt T. Transient expression of the cholecystokinin gene in male germ cells and accumulation of the peptide in the acrosomal granule: possible role of cholecystokinin in fertilization. Proc Natl Acad Sci U S A (1989) 86:6166-70. doi:10.1073/pnas.86.16.6166
101. Schalling M, Persson H, Pelto-Huikko M, Odum L, Ekman P, Gottlieb C, et al. Expression and localization of gastrin messenger RNA and peptide in spermatogenic cells. J Clin Invest (1990) 86:660-9. doi:10.1172/JCI114758
102. Aunapuu M, Roosaar P, Järveots T, Kurrikoff K, Kõks S, Vasar E, et al. Altered renal morphology in transgenic mice with cholecystokinin overexpression. Transgenic Res (2008) 17:1079-89. doi:10.1007/s11248-008-9204-5
103. Miyamoto S, Shikata K, Miyasaka K, Okada S, Sasaki M, Kodera R, et al. Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin. Diabetes (2012) 61:897-907. doi:10.2337/db11-0402
104. de Weerth A, Jonas L, Schade R, Schöneberg T, Wolf G, Pace A, et al. Gastrin/cholecystokinin type B receptors in the kidney: molecular, pharmacological, functional characterization, and localization. Eur J Clin Invest (1998) 28:592-601. doi:10.1046/j.1365-2362.1998.00310.x
105. von Schrenck T, de Weerth A, Bechtel S, Eschenhagen T, Weil J, Wolf G, et al. Evidence for CCK(B) receptors in the guinea-pig kidney: localization and characterization by 125I-gastrin binding studies and by RT-PCR. Naunyn Schmiedebergs Arch Pharmacol (1998) 358:287-92. doi:10.1007/PL00005255
106. Okahata H, Nishi Y, Muraki K, Sumii K, Miyachi Y, Usui T. Gastrin/cholecystokinin-like immunoreactivity in human blood cells. Life Sci (1985) 36:369-73. doi:10.1016/0024-3205(85)90123-7
107. Sacerdote P, Breda M, Barcellini W, Meroni PL, Panerai AE. Age-related changes of beta-endorphin and cholecystokinin in human and rat mononuclear cells. Peptides (1991) 12:1353-6. doi:10.1016/0196-9781(91)90219-F
108. De la Fuente M, Carrasco M, Del Rio M, Hernanz A. Modulation of murine lymphocyte functions by sulfated cholecystokinin octapeptide. Neuropeptides (1998) 32:225-33. doi:10.1016/S0143-4179(98)90041-5
109. Carrasco M, Del Rio M, Hernanz A, De la Fuente M. Inhibition of human neutrophil functions by sulfated and nonsulfated cholecystokinin octapeptides. Peptides (1997) 18:415-22. doi:10.1016/S0196-9781(96)00338-5
110. Meng AH, Ling YL, Zhang XP, Zhang JL. Anti-inflammatory effect of cholecystokinin and its signal transduction mechanism in endotoxic shock rat. World J Gastroenterol (2002) 8:712-7. doi:10.3748/wjg.v8.i4.712
111. Li S, Ni Z, Cong B, Gao W, Xu S, Wang C, et al. CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway. Shock (2007) 27:678-86. doi:10.1097/shk.0b013e3180ze26dd
112. Lay JM, Gillespie PJ, Samuelson LC. Murine prenatal expression of cholecystokinin in neural crest, enteric neurons, and enteroendocrine cells. Dev Dyn (1999) 216:190-200. doi:10.1002/(SICI)1097-0177(199910)216:2<190::AID-DVDY9>3.0.CO;2-K
113. Goetze JP, Johnsen AH, Kistorp C, Gustafsson F, Johnbeck CB, Rehfeld JF. Cardiomyocyte expression and cell-specific processing of procholecystokinin. J Biol Chem (2015) 290:6837-43. doi:10.1074/jbc.M114.622670
114. Madsen OD, Larsson LI, Rehfeld JF, Schwartz TW, Lernmark A, Labrecque AD, et al. Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol (1986) 103:2025-34. doi:10.1083/jcb.103.5.2025
115. Madsen OD, Karlsen C, Nielsen E, Lund K, Kofod H, Welinder B, et al. The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable alpha-and beta-cell tumor phenotypes. Endocrinology (1993) 133:2022-30. doi:10.1210/endo.133.5.8404649
116. Rehfeld JF, Federspiel B, Bardram L. A neuroendocrine tumor syndrome from cholecystokinin secretion. N Engl J Med (2013) 368:1165-6. doi:10.1056/NEJMc1215137
117. Rehfeld JF, Federspiel B, Agersnap M, Knigge U, Bardram L. The uncovering and characterization of a CCKoma syndrome in enteropancreatic neuroendocrine tumor patients. Scand J Gastroenterol (2016) 51:1172-8. doi:10.1080/00365521.2016.1183706
118. Reubi JC, Koefoed P, Hansen TV, Stauffer E, Rauch D, Nielsen FC, et al. Procholecystokinin as marker of human Ewing sarcomas. Clin Cancer Res (2004) 10:5523-30. doi:10.1158/1078-0432.CCR-1015-03
119. Oikonomou E, Buchfelder M, Adams EF. Cholecystokinin (CCK) and CCK receptor expression by human gliomas: evidence for an autocrine/paracrine stimulatory loop. Neuropeptides (2008) 42:255-65. doi:10.1016/j.npep.2008.02.005
120. Camby I, Salmon I, Danguy A, Pasteels JL, Brotchi J, Martinez J, et al. Influence of gastrin on human astrocytic tumor cell proliferation. J Natl Cancer Inst (1996) 88:594-600. doi:10.1093/jnci/88.9.594
121. Rehfeld JF, van Solinge WW, Tos M, Thomsen J. Gastrin, cholecystokinin and their precursors in acoustic neuromas. Brain Res (1990) 530:235-8. doi:10.1016/0006-8993(90)91288-R
122. Rehfeld JF. Cholecystokinin expression in tumors: biogenetic and diagnostic implications. Future Oncol (2016) 12:2135-47. doi:10.2217/fon-2015-0053